Welcome to LookChem.com Sign In|Join Free
  • or
4-(Trifluoromethyl)piperidine is an organic compound that features a piperidine ring with a trifluoromethyl group attached at the 4-position. 4-(Trifluoromethyl)piperidine is known for its unique chemical properties and is a valuable building block in the synthesis of various pharmaceuticals and agrochemicals.

657-36-3

Post Buying Request

657-36-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

657-36-3 Usage

Uses

Used in Pharmaceutical Industry:
4-(Trifluoromethyl)piperidine is used as a key intermediate in the synthesis of retinoid-related orphan receptor (ROR) inhibitors. These ROR inhibitors are important for the development of drugs targeting various diseases, including autoimmune disorders, neurodegenerative diseases, and cancer. The trifluoromethyl group in 4-(Trifluoromethyl)piperidine contributes to the enhanced potency and selectivity of the resulting ROR inhibitors.
Additionally, 4-(Trifluoromethyl)piperidine can be utilized in the development of other bioactive molecules due to its unique structural features and synthetic versatility. Its applications may extend to various therapeutic areas, making it a valuable compound in the pharmaceutical industry.

Check Digit Verification of cas no

The CAS Registry Mumber 657-36-3 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 6,5 and 7 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 657-36:
(5*6)+(4*5)+(3*7)+(2*3)+(1*6)=83
83 % 10 = 3
So 657-36-3 is a valid CAS Registry Number.
InChI:InChI=1/C6H10F3N/c7-6(8,9)5-1-3-10-4-2-5/h5,10H,1-4H2

657-36-3 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (T3081)  4-(Trifluoromethyl)piperidine  >97.0%(GC)(T)

  • 657-36-3

  • 1g

  • 890.00CNY

  • Detail
  • TCI America

  • (T3081)  4-(Trifluoromethyl)piperidine  >97.0%(GC)(T)

  • 657-36-3

  • 5g

  • 3,390.00CNY

  • Detail
  • Alfa Aesar

  • (H64840)  4-(Trifluoromethyl)piperidine, 97%   

  • 657-36-3

  • 250mg

  • 490.0CNY

  • Detail
  • Alfa Aesar

  • (H64840)  4-(Trifluoromethyl)piperidine, 97%   

  • 657-36-3

  • 1g

  • 1470.0CNY

  • Detail
  • Alfa Aesar

  • (H64840)  4-(Trifluoromethyl)piperidine, 97%   

  • 657-36-3

  • 5g

  • 5880.0CNY

  • Detail

657-36-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-(Trifluoromethyl)piperidine

1.2 Other means of identification

Product number -
Other names 4-(TRIFLUOROMETHYL)PIPERIDINE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:657-36-3 SDS

657-36-3Downstream Products

657-36-3Relevant academic research and scientific papers

Symbiotic prodrugs (SymProDs) dual targeting of NFkappaB and CDK

Rana, Sandeep,Kour, Smit,Sonawane, Yogesh A.,Robb, Caroline M.,Contreras, Jacob I.,Kizhake, Smitha,Zahid, Muhammad,Karpf, Adam R.,Natarajan, Amarnath

, p. 773 - 784 (2020/04/29)

The release of an active drug from the prodrug generates a pro-fragment that typically has no biological activity and could result in adverse effects. By combining two drugs, wherein each drug acts as a pro-fragment of the other drug will eliminate the pr

A General Catalyst Based on Cobalt Core–Shell Nanoparticles for the Hydrogenation of N-Heteroarenes Including Pyridines

Beller, Matthias,Chandrashekhar, Vishwas G.,Jagadeesh, Rajenahally V.,Kreyenschulte, Carsten,Murugesan, Kathiravan

supporting information, p. 17408 - 17412 (2020/08/21)

Herein, we report the synthesis of specific silica-supported Co/Co3O4 core–shell based nanoparticles prepared by template synthesis of cobalt-pyromellitic acid on silica and subsequent pyrolysis. The optimal catalyst material allows for general and selective hydrogenation of pyridines, quinolines, and other heteroarenes including acridine, phenanthroline, naphthyridine, quinoxaline, imidazo[1,2-a]pyridine, and indole under comparably mild reaction conditions. In addition, recycling of these Co nanoparticles and their ability for dehydrogenation catalysis are showcased.

The merger of decatungstate and copper catalysis to enable aliphatic C(sp 3)–H trifluoromethylation

Sarver, Patrick J.,Bacauanu, Vlad,Schultz, Danielle M.,DiRocco, Daniel A.,Lam, Yu-hong,Sherer, Edward C.,MacMillan, David W. C.

, p. 459 - 467 (2020/03/23)

The introduction of a trifluoromethyl (CF3) group can dramatically improve a compound’s biological properties. Despite the well-established importance of trifluoromethylated compounds, general methods for the trifluoromethylation of alkyl C–H bonds remain elusive. Here we report the development of a dual-catalytic C(sp3)–H trifluoromethylation through the merger of light-driven, decatungstate-catalysed hydrogen atom transfer and copper catalysis. This metallaphotoredox methodology enables the direct conversion of both strong aliphatic and benzylic C–H bonds into the corresponding C(sp3)–CF3 products in a single step using a bench-stable, commercially available trifluoromethylation reagent. The reaction requires only a single equivalent of substrate and proceeds with excellent selectivity for positions distal to unprotected amines. To demonstrate the utility of this new methodology for late-stage functionalization, we have directly derivatized a broad range of approved drugs and natural products to generate valuable trifluoromethylated analogues. Preliminary mechanistic experiments reveal that a ‘Cu–CF3’ species is formed during this process and the critical C(sp3)–CF3 bond-forming step involves the copper catalyst. [Figure not available: see fulltext.].

Accessing Difluoromethylated and Trifluoromethylated cis-Cycloalkanes and Saturated Heterocycles: Preferential Hydrogen Addition to the Substitution Sites for Dearomatization

Zhang, Xue,Ling, Liang,Luo, Meiming,Zeng, Xiaoming

supporting information, p. 16785 - 16789 (2019/11/11)

Reported here is a straightforward process in which a cyclic (alkyl)(amino)carbene/Rh catalyst system facilitates the preferential addition of hydrogen to the substitution sites of difluoromethylated and trifluoromethylated arenes and heteroarenes, leading to dearomative reduction. This strategy enables the diastereoselective synthesis of cis-difluoromethylated and cis-trifluoromethylated cycloalkanes and saturated heterocycles, and even allows formation of all-cis multi-trifluoromethylated cyclic products with a defined equatorial orientation of the di- and trifluoromethyl groups. Deuterium-labeling studies indicate that hydrogen preferentially attacks the substitution sites of planar arenes, resulting in dearomatization, possibly with heterogeneous Rh as the reactive species, followed by either reversible or irreversible hydrogen addition to the nonsubstitution sites.

NHC-stabilised Rh nanoparticles: Surface study and application in the catalytic hydrogenation of aromatic substrates

Martinez-Espinar, Francisco,Blondeau, Pascal,Nolis, Pau,Chaudret, Bruno,Claver, Carmen,Castillón, Sergio,Godard, Cyril

, p. 113 - 127 (2017/09/08)

New Rh-NPs stabilised by N-Heterocyclic Carbenes (NHC) were synthesized by decomposition of [Rh(η3-C3H5)3] under H2 atmosphere and fully characterized. Surface studies by FT-IR and NMR spectroscopy employing isotopically labelled ligands were also performed. The Rh0.2 NPs are active catalysts in the reduction of various aromatic substrates. In the reduction of phenol, high selectivities to cyclohexanone or cyclohexanol were obtained depending on the reaction conditions. However, this catalytic system exhibited much lower activity in the hydrogenation of substituted phenols. Pyridine was easily hydrogenated under mild conditions and interestingly, the hydrogenation of 4-methyl and 4-trifluoromethylpyridine resulted slower than that of 2-methylpyridine. The hydrogenation of 1-(pyridin-2-yl)propan-2-one provided the β-enaminone 13a in high yield as a consequence of the partial reduction of the pyridine ring followed by isomerization. Quinoline could be either partially hydrogenated to 1,2,3,4-tetrahydroquinoline or fully reduced to decahydroquinoline by adjusting the reaction conditions.

Benzothiazole derivatives with activity as adenosine receptor ligands

-

, (2008/06/13)

The present invention relates to substituted benzothiazole derivitives and to their pharmaceutically acceptable salts useful for the treatment of diseases related to the adenosine receptor.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 657-36-3